Keybank National Association OH Acquires 26,412 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Keybank National Association OH grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 86.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,974 shares of the company’s stock after acquiring an additional 26,412 shares during the quarter. Keybank National Association OH’s holdings in LifeStance Health Group were worth $420,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of LFST. Principal Financial Group Inc. boosted its position in shares of LifeStance Health Group by 6.1% during the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock worth $28,817,000 after buying an additional 235,316 shares during the period. Jennison Associates LLC boosted its position in shares of LifeStance Health Group by 9.5% during the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock worth $14,959,000 after buying an additional 184,896 shares during the period. Intech Investment Management LLC acquired a new position in shares of LifeStance Health Group during the third quarter worth about $311,000. Landscape Capital Management L.L.C. boosted its position in shares of LifeStance Health Group by 43.7% during the third quarter. Landscape Capital Management L.L.C. now owns 367,935 shares of the company’s stock worth $2,576,000 after buying an additional 111,894 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock worth $7,731,000 after buying an additional 297,723 shares during the period. 85.50% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

LFST has been the subject of several recent research reports. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Barclays upped their price objective on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. Finally, The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, LifeStance Health Group currently has a consensus rating of “Hold” and an average target price of $8.63.

LifeStance Health Group Stock Performance

Shares of NASDAQ LFST opened at $7.59 on Monday. The stock has a 50 day moving average price of $7.86 and a 200 day moving average price of $7.32. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $8.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a market capitalization of $2.92 billion, a PE ratio of -29.19 and a beta of 1.27.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.